Search research articles
Contact Us
Filters
Showing results (61-70 of 185) with videos related to
Page
of 19
Sort By:
Seminars in Oncology
|
February 1, 1990
Single-agent oral etoposide for elderly small cell lung cancer patients
D N Carney, L Grogan, E F Smit, et al.
Chest
|
June 20, 2000
Outcome of bronchial carcinoma in situ
B J Venmans, T J van Boxem, E F Smit, et al.
The Annals of Otology, Rhinology, and Laryngology
|
July 24, 2001
Bronchial intraepithelial neoplastic lesions in head and neck cancer patients: results of autofluorescence bronchoscopy
B J Venmans, T J van Boxem, E F Smit, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
December 6, 2013
Effects of chemotherapy on the parotid and submandibular glands in head and neck cancer patients treated with chemoradiotherapy
A A M van der Veldt, E F Smit, E F I Comans, et al.
Medical Physics
|
May 3, 2013
CT-perfusion versus [(15)O]H2O PET in lung tumors: effects of CT-perfusion methodology
G M Kramer, M Yaqub, I Bahce, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 12, 2004
Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA
J T Annema, O S Hoekstra, E F Smit, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 6, 2017
Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry
C Dickhoff, M Dahele, E F Smit, et al.
The American Journal of Medicine
|
August 1, 1990
Decreased phenytoin level after carboplatin treatment
A S Dofferhoff, H H Berendsen, J vd Naalt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 24, 2003
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965)
R Dziadziuszko, A Ardizzoni, P E Postmus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2014
High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib
J L Kuiper, D A M Heideman, E Thunnissen, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 185) with videos related to
Sort By:
Page
of 19
Seminars in Oncology
|
February 1, 1990
Single-agent oral etoposide for elderly small cell lung cancer patients
D N Carney, L Grogan, E F Smit, et al.
Chest
|
June 20, 2000
Outcome of bronchial carcinoma in situ
B J Venmans, T J van Boxem, E F Smit, et al.
The Annals of Otology, Rhinology, and Laryngology
|
July 24, 2001
Bronchial intraepithelial neoplastic lesions in head and neck cancer patients: results of autofluorescence bronchoscopy
B J Venmans, T J van Boxem, E F Smit, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
December 6, 2013
Effects of chemotherapy on the parotid and submandibular glands in head and neck cancer patients treated with chemoradiotherapy
A A M van der Veldt, E F Smit, E F I Comans, et al.
Medical Physics
|
May 3, 2013
CT-perfusion versus [(15)O]H2O PET in lung tumors: effects of CT-perfusion methodology
G M Kramer, M Yaqub, I Bahce, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 12, 2004
Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA
J T Annema, O S Hoekstra, E F Smit, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 6, 2017
Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry
C Dickhoff, M Dahele, E F Smit, et al.
The American Journal of Medicine
|
August 1, 1990
Decreased phenytoin level after carboplatin treatment
A S Dofferhoff, H H Berendsen, J vd Naalt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 24, 2003
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965)
R Dziadziuszko, A Ardizzoni, P E Postmus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2014
High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib
J L Kuiper, D A M Heideman, E Thunnissen, et al.
Page
of 19